Home
Conditions
Lymphoma, B-Cell, Marginal Zone

Clinical trial condition

Lymphoma, B-Cell, Marginal Zone

Explore clinical trials studying Lymphoma, B-Cell, Marginal Zone. Study availability and eligibility vary by location and protocol.

646 public trials 88 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, B-Cell, Marginal Zone trial results

Completed

First-line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance.

NCT00801281

Conditions: Chronic Disease, Disease Attributes, Follicular Lymphoma, +22 more
Locations: Podkarpacki Oncology Centre Brzozów, Poland

Voivodeship Hospital, Oncology Ward Elblag, Poland

Academic Clinical Centre, Hospital of Medical Academy, Clinic of Haematology and Transplantology Gdansk, Poland

Silesian Medical University, Chair and Clinic of Haematology and Bone Marrow Transplantation Katowice, Poland

View Trial Details

Completed

Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen

NCT00448357

Conditions: Blast Crisis, Blood Coagulation Disorders, Blood Platelet Disorders, +72 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Completed

Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies

NCT00072514

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +80 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

A Study of TRU-016 in Combination With Rituximab and Bendamustine in Subjects With Relapsed Indolent Lymphoma

NCT01317901

Conditions: B-cell Small Lymphocytic Lymphoma Recurrent, Chronic Disease, Disease Attributes, +19 more
Locations: Site Reference ID/Investigator# 61543 Birmingham, Alabama, United States

Site Reference ID/Investigator# 61542 Augusta, Georgia, United States

Site Reference ID/Investigator# 61523 Omaha, Nebraska, United States

Site Reference ID/Investigator# 61522 Hackensack, New Jersey, United States

View Trial Details

Completed

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant

NCT00691015

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +57 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Interaction Study of Ibrutinib and Cytochrome P450 (CYP) 3A Inhibitors in Participants With B-cell Malignancy

NCT02381080

Conditions: B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +28 more
Locations: N/a N/a, Canada

Moscow, Russia

Petrozavodsk, Russia

Saint Petersburg, Russia

View Trial Details

Completed

Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

NCT00448201

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +66 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Completed

Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases

NCT00376922

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +101 more
Locations: Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Completed

Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

NCT00118352

Conditions: Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, +135 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

University of Torino Torino, Italy

View Trial Details

Completed

Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants

NCT00899496

Conditions: Adenocarcinoma, Adnexal Diseases, Blood Protein Disorders, +122 more
Locations: Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Lymphoma, B-Cell, Marginal Zone

Lymphoma, B-Cell, Marginal Zone trial results

Related conditions